| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |